Susceptibility breakpoint for enrofloxacin against swine Salmonella spp

Haihong Hao1, Huafang Pan, Ijaz Ahmad

  • 1National Reference Laboratory of Veterinary Drug Residues/MOA Key Laboratory of the Detection of Veterinary Drug Residues, Huazhong Agricultural University, Wuhan, Hubei, People's Republic of China.

Insights

This study establishes the first enrofloxacin susceptibility breakpoint for swine Salmonella, setting a MIC of ≤ 0.25 μg/ml. This provides a vital criterion for antimicrobial susceptibility testing and clinical use in pigs.

Area of Science:

  • Veterinary Microbiology
  • Antimicrobial Resistance
  • Food Animal Health

Background:

  • Prudent antimicrobial use is essential in livestock production.
  • Salmonella spp. in swine pose a significant food safety and animal health challenge.
  • Enrofloxacin is a critical antimicrobial for treating bacterial infections in food animals.

Purpose of the Study:

  • To establish the first susceptibility breakpoint for enrofloxacin against swine Salmonella spp.
  • To provide a reliable criterion for enrofloxacin susceptibility testing in veterinary diagnostics.
  • To guide the clinical application of enrofloxacin in swine Salmonella infections.

Main Methods:

  • Determination of wild-type cutoff (COWT) values.
  • Calculation of pharmacokinetic-pharmacodynamic (PK-PD) cutoff (COPD) values.
  • MIC determination for enrofloxacin against swine Salmonella isolates.

Main Results:

  • The first susceptibility breakpoint for enrofloxacin against swine Salmonella spp. was developed.
  • The established breakpoint is a minimum inhibitory concentration (MIC) of ≤ 0.25 μg/ml.
  • This breakpoint is based on both COWT and COPD values.

Conclusions:

  • A validated susceptibility breakpoint for enrofloxacin in swine Salmonella is now available.
  • This breakpoint facilitates accurate susceptibility testing and informed clinical decisions.
  • This contributes to responsible antimicrobial stewardship in swine production.